Clinical Features and Management of COVID-19-Associated Hypercoagulability.
Card Electrophysiol Clin
; 14(1): 41-52, 2022 03.
Article
in English
| MEDLINE | ID: covidwho-1487627
ABSTRACT
COVID-19 is an acute respiratory disease of viral origin caused by SARS-CoV-2. This disease is associated with a hypercoagulable state resulting in arterial and venous thrombotic events. The latter are more frequent, especially in patients who develop a severe form of the disease and are associated with an increased mortality rate. It is therefore essential to identify patients at higher risk to initiate antithrombotic therapy. Hospitalized patients treated with treatment dose of anticoagulants had better outcomes than those treated with prophylactic dose. However, several trials are ongoing to better define the therapeutic and prevention strategies for this insidious complication.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Thrombophilia
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Card Electrophysiol Clin
Year:
2022
Document Type:
Article
Affiliation country:
J.ccep.2021.10.005
Similar
MEDLINE
...
LILACS
LIS